MME and Myocardial fibrosis: The reason why S/V is superior to beta-blockers, ACEI, and MRAs mainly because of the beneficial effects of neprilysin inhibition resulting in reducing myocardial fibrosis and improving cardiac remodeling by relieving wall stress, inflammation, hypertrophy, and cell death.